JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ando, H.
Right arrow Articles by Kobayashi, K.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ando, H.
Right arrow Articles by Kobayashi, K.-i.

Vol. 294, Issue 3, 1043-1046, September 2000

Cerivastatin Improves Survival of Mice with Lipopolysaccharide-Induced Sepsis

Hitoshi Ando, Toshinari Takamura, Tsuguhito Ota, Yukihiro Nagai and Ken-ichi Kobayashi

The First Department of Internal Medicine, School of Medicine, Kanazawa University, Kanazawa, Japan

Development of severe sepsis is thought to result from the overproduction of cytokines, such as tumor necrosis factor-alpha (TNF-alpha ) and interleukin-1beta (IL-1beta ), and nitric oxide. Recently, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, which are antihypercholesterolemic agents, have been reported to inhibit lipopolysaccharide (LPS)-induced production of cytokines and nitric oxide in vitro. In this study, we tested these effects in vivo. After LPS administration (15 mg/kg i.p.) to CD-1 mice, serum levels of both TNF-alpha and IL-1beta transiently increased, and peaked at 2 h. After the peak responses of TNF-alpha and IL-1beta , serum levels of nitrite and nitrate increased until at least 8 h. Pretreatment of the mice with cerivastatin (20 mg/kg i.p. 12 and 1 h before LPS injection) reduced serum levels of TNF-alpha and IL-1beta at 2 h, and nitrite and nitrate at 8 h, by 93, 60, and 44%, respectively. In this model of sepsis, cerivastatin significantly (P = .016) improved the rate of 7-day survival from 26.7 to 73.3%. These results cast new light on the usefulness of cerivastatin in preventing severe sepsis.

0022-3565/00/2943-1043$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Innate ImmunityHome page
J. Reis, Xiaoyu Tan, Rongjie Yang, C. E. Rockwell, C. J. Papasian, S. N. Vogel, D. C. Morrison, A. A. Qureshi, and N. Qureshi
A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model
Innate Immunity, October 1, 2008; 14(5): 319 - 329.
[Abstract] [PDF]

Home page
 Br J AnaesthHome page
F. Gao, L. Linhartova, A. McD. Johnston, and D. R. Thickett
Statins and sepsis
Br. J. Anaesth., March 1, 2008; 100(3): 288 - 298.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. Gupta, L. C. Plantinga, N. E. Fink, M. L. Melamed, J. Coresh, C. S. Fox, N. W. Levin, and N. R. Powe
Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease
JAMA, April 4, 2007; 297(13): 1455 - 1464.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
C. C. McGown and Z. L. S. Brookes
Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide
Br. J. Anaesth., February 1, 2007; 98(2): 163 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Banaszewska, L. Pawelczyk, R. Z. Spaczynski, J. Dziura, and A. J. Duleba
Effects of Simvastatin and Oral Contraceptive Agent on Polycystic Ovary Syndrome: Prospective, Randomized, Crossover Trial
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 456 - 461.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
A. P. Anisimov and K. K. Amoako
Treatment of plague: promising alternatives to antibiotics.
J. Med. Microbiol., November 1, 2006; 55(Pt 11): 1461 - 1475.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. C. Alves-Filho and F. Q. Cunha
Modulation of toll-like receptor expression: a further effect of statins?
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): e128 - e128.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
V. Liebe, M. Brueckmann, M. Borggrefe, and J. J. Kaden
Statin therapy of calcific aortic stenosis: hype or hope?
Eur. Heart J., April 1, 2006; 27(7): 773 - 778.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. Erkkila, M. Jauhiainen, K. Laitinen, K. Haasio, T. Tiirola, P. Saikku, and M. Leinonen
Effect of Simvastatin, an Established Lipid-Lowering Drug, on Pulmonary Chlamydia pneumoniae Infection in Mice
Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3959 - 3962.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. B. Fessler, S. K. Young, S. Jeyaseelan, J. G. Lieber, P. G. Arndt, J. A. Nick, and G. S. Worthen
A Role for Hydroxy-Methylglutaryl Coenzyme A Reductase in Pulmonary Inflammation and Host Defense
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 606 - 615.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. S. Kang, Y. D. Yoon, I. J. Cho, M. H. Han, C. W. Lee, S.-K. Park, and H. M. Kim
Glabridin, an Isoflavan from Licorice Root, Inhibits Inducible Nitric-Oxide Synthase Expression and Improves Survival of Mice in Experimental Model of Septic Shock
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1187 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Sironi, E. Gianazza, P. Gelosa, U. Guerrini, E. Nobili, A. Gianella, B. Cremonesi, R. Paoletti, and E. Tremoli
Rosuvastatin, but not Simvastatin, Provides End-Organ Protection in Stroke-Prone Rats by Antiinflammatory Effects
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 598 - 603.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. L. Stoll, G. M. Denning, and N. L. Weintraub
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2227 - 2236.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Ando, S. Tsuruoka, H. Yamamoto, T. Takamura, S. Kaneko, and A. Fujimura
Effects of Pravastatin on the Expression of ATP-Binding Cassette Transporter A1
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 420 - 425.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. Stamm, M. W. Merx, U. Janssens, P. Hanrath, E. A. Liehn, C. Weber, R. Lutticken, and J. Schrader
Simvastatin and Survival in Sepsis * Response
Circulation, September 21, 2004; 110(12): e315 - e315.
[Full Text] [PDF]

Home page
 CirculationHome page
Y. Almog, A. Shefer, V. Novack, N. Maimon, L. Barski, M. Eizinger, M. Friger, L. Zeller, and A. Danon
Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis
Circulation, August 17, 2004; 110(7): 880 - 885.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. I. McFarlane, R. Muniyappa, R. Francisco, and J. R. Sowers
Pleiotropic Effects of Statins: Lipid Reduction and Beyond
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1451 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz
Changes in Proinflammatory Cytokine Activity after Menopause
Endocr. Rev., February 1, 2002; 23(1): 90 - 119.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.